PharmaVitae 2005: Bristol-Myers Squibb Global and US Analysis
Price:
$5 700.00
Introduction
This analysis examines the current position and future outlook for Bristol-Myers Squibb in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Reasons to Purchase
Benchmark Bristol Myers Squibb’s performance against key rivals in the ethical pharmaceutical and biotechnology sector.
Gain insight into why Bristol-Myers Squibb’s generic risk is one of the highest among the top-tier pharmaceutical companies.
